Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer
Clinical trial NCT04252365 · UNKNOWN
Trial details
- NCT number
- NCT04252365
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2021-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.